NEW YORK (GenomeWeb News) – Definiens and Bioscan have signed an agreement to co-market Bioscan’s instruments for noninvasive in vivo animal imaging with Definiens’ image analysis software, the companies said today.

 

Bioscan, based in Morristown, NJ, and Definiens, based in Munich, Germany, said they have agreed to “conduct cooperative marketing activities and host joint workshops and events” that will offer customers integrated training and implementation programs.